We are live on ! Find out more
ACIU icon

AC Immune
ACIU

31 hedge funds and large institutions have $136M invested in AC Immune in 2016 Q3 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14.38% more ownership

Funds ownership: 0% → 14.38% (+14%)

Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$55.4M
2
DFO
Duquesne Family Office
New York
+$25.9M
3
Temasek Holdings
Temasek Holdings
Singapore
+$23.1M
4
HIM
Hillhouse Investment Management
Cayman Islands
+$9.5M
5
PC
PointState Capital
New York
+$7.34M

Top Sellers

No sellers this quarter

ACIU Hedge Fund Activity: Q3 2016 in Review

31 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2016, worth a combined $136M.

Buyers outnumbered sellers: 31 funds opened new ACIU positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $55.4M.

  • 31 institutional investors held AC Immune (ACIU) as of Q3 2016, up from 0 in Q2 2016.
  • Funds reported $136M of AC Immune stock for Q3 2016.
  • 31 funds opened new AC Immune positions in Q3 2016 and 0 closed out, a net change of +31 holders.
  • The largest AC Immune buyer in Q3 2016 was Fidelity Investments, an estimated $55.4M added.

Based on aggregated 13F filings for Q3 2016.